Apidra 100 IU/Mi Vial

Composition of Apidra 100 IU/Mi Vial

Apidra 100 IU/Mi Vial contains Insulin Glulisine (100IU). It belongs to the Rapid-acting insulin analog class of medicines.

Uses of Apidra 100 IU/Mi Vial

Treatment of diabetes mellitus (Type 1 and Type 2) to control high blood sugar; used as rapid-acting mealtime insulin with a longer-acting basal insulin regimen as advised

Key benefits

• Rapid control of post-meal blood sugar
• Helps maintain overall glycaemic control
• Flexible dosing around meals (as prescribed)
• Reduces symptoms/complications related to hyperglycaemia

How Apidra 100 IU/Mi Vial works

Insulin glulisine is a rapid-acting insulin analog that replaces/augments insulin to help glucose enter muscle and fat cells and reduces glucose production by the liver. It lowers blood sugar quickly after injection, especially around meals.

How to take Apidra 100 IU/Mi Vial

Injection (vial): Use only as prescribed. Typically injected subcutaneously shortly (0–15 minutes) before a meal or immediately after starting a meal. Dose and timing depend on blood glucose, meal pattern and other insulin/antidiabetic therapy. Use appropriate insulin syringe; do not share needles/syringes. May be used in insulin pumps if specifically advised; follow device instructions and healthcare guidance.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Contact your doctor or diabetes nurse for advice — do not take a double dose to make up for a missed injection.

If you take too much

An overdose of this medicine can cause severe low blood sugar, leading to fits or unconsciousness — this is a medical emergency. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Apidra 100 IU/Mi Vial

Most side effects of Apidra are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia (low blood sugar)
• injection site reactions (pain/redness/swelling/itching)
• weight gain
• lipodystrophy at injection site
• allergic reactions (rash/urticaria)
• oedema

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Apidra 100 IU/Mi Vial

Warnings and precautions

Risk of hypoglycaemia—carry glucose/sugar and monitor blood glucose regularly. Rotate injection sites to reduce lipodystrophy. Do not use during episodes of hypoglycaemia. Use with caution in kidney or liver impairment (may need dose adjustment). Severe allergy to insulin or excipients is a contraindication—seek urgent care for breathing difficulty, swelling or generalized rash. Illness, stress, meal changes and exercise can alter insulin needs. Use only clear, colorless solution; do not use if cloudy/particles. Do not mix with other insulins unless specifically advised by doctor (and follow product guidance).

Do not take Apidra if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not to be used during an episode of low blood sugar.

Interactions with other medicines

Other antidiabetics (increased hypoglycaemia risk),beta-blockers (may mask hypoglycaemia symptoms),ACE inhibitors/ARBs (may increase hypoglycaemia risk),corticosteroids/thyroid hormones/thiazide diuretics/sympathomimetics (may increase blood glucose),alcohol (may cause hypo- or hyperglycaemia),MAO inhibitors/salicylates (may enhance insulin effect)

How to store Apidra 100 IU/Mi Vial

Store unopened vials in a refrigerator at 2–8°C; do not freeze. Protect from light. After opening, keep as per label instructions; generally keep below 25°C and use within the in-use period specified by the manufacturer. Keep vial away from heat and direct sunlight.

Expert advice for Apidra 100 IU/Mi Vial

Keep an unopened supply in the fridge and the pen in use at room temperature, away from direct sunlight. Always carry a fast-acting sugar source. Check your sugar as your doctor has instructed, and keep a record to take to appointments.

Manufacturer and class

Manufacturer:

SANOFI INDIA LTD

Therapeutic class:

Antidiabetic

Drug class:

Rapid-acting insulin analog